Table 1.
Patient characteristics of patients with very high LDL-C in DUHS and cerner.a.
| Characteristic | Duke Health (N = 7728) | Cerner (N = 139,539) |
|---|---|---|
| Age | 57 (48, 66) | 56 (48–66) |
| Sex (female) | 63.9% (4938) | 64.6% (82508) |
| Race | ||
| Caucasian | 67.7% (5230) | 84.6% (98112) |
| African American | 24.9% (1928) | 8.6% (10021) |
| Other | 2.5% (190) | 3.6% (4153) |
| Hispanic | 1.8% (136) | 2.2% (2551) |
| Asian | 3.0% (234) | 1.0% (1185) |
| Insurance | ||
| Commercial | 65.3% (4921) | 53.2% (40392) |
| Government | 34.2% (2577) | 41.4% (31438) |
| No insurance | 2.5% (191) | 4.8% (3671) |
| Other | 0.5% (39) | 0.6% (455) |
| SBP, mmHg | 124 (116, 138) | |
| Baseline LDL-C (mg/dL) | 203 (195, 217) | 204 (196–219) |
| Comorbidities | ||
| Hypertension | 27.2% (2105) | 19.1% (26636) |
| Diabetes | ||
| Type 1 | 0.3% (21) | 0.7% (934) |
| Type 2 | 9.3% (720) | 8.0% (11119) |
| ASCVD | 6.1% (473) | 4.6% (6447) |
| Heart failure | 0.9% (73) | 0.9% (1315) |
| PAD (PAD + AAA) | 0.8% (59) | 0.4% (598) |
| Coronary heart disease | 4.0% (307) | 3.6 (5014) |
| Cerebrovascular disease (CVD + strokes) | 2.0% (153) | 1.1% (1478) |
| Hypothyroidism | 10.1% (784) | 7.4% (10370) |
| Hyperthyroidism | 0.5% (41) | 0.5% (686) |
| Nephrotic syndrome | 0.0% (0) | 0.1% (148) |
| BMI | 29 (26, 33) | |
| Family history of MI | 15.9% (1228) | |
| Current smoker | 11.0% (838) | |
| Meeting guideline recommendation without LDL-C considered | 50.7% (3916) | |
| No ASCVD and calculated risk ≤7.5% | 50.5% (2337) | |
| ASCVD 10-year risk | 7.5 (3.8, 14.3) | |
| Provider type | ||
| Cardiology | 2.8% (217) | 2.5% (3467) |
| Endocrinology | 2.4% (186) | 0.3% (413) |
| Primary care: internal | 55.5% (4285) | 12.1% (16914) |
| Primary care: family | 31.3% (2419) | 23.5% (32742) |
| Other provider type or not otherwise specified | 8.0% (621) | 61.6% (86,003) |
| Facility type | ||
| Urban | 87.7% (122423) | |
| Rural | 12.3% (17116) | |
| Facility region | ||
| Midwest | 10.7% (14886) | |
| Northeast | 55.6% (77644) | |
| South | 15.6% (21744) | |
| West | 18.1% (25265) | |
| Baseline treatment | ||
| None | 86.8% (6707) | |
| Non-statin only | 1.9% (148) | |
| Low-intensity statin | 2.2% (171) | |
| Moderate-intensity statin | 5.4% (418) | |
| High-intensity statin | 3.7% (284) | |
Abbreviations: AAA, abdominal aortic aneurysm; ASCVD, atherosclerotic cardiovascular disease; CVD, cardiovascular disease; DUHS, Duke University Health System; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; PAD, peripheral artery disease. Where cells are blank, data unavilable for that data source.
a
Data presented as median (25th, 75th percentile) or percentage (N). All calculations are made as the percentage of non-missing values.